Clinical trial participants' views of the risks and benefits of data sharing

New England Journal of Medicine

Volumn 378, Issue 23, 2018, Pages 2202-2211

  Mello, Michelle M ^a,b   Lieou, Van ^a   Goodman, Steven N ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD LAW SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE; CLINICAL TRIAL (TOPIC); DATA SHARING; FEMALE; HEALTH STATUS; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; RESEARCH SUBJECT; RISK BENEFIT ANALYSIS; SCIENTIST; UNITED STATES; UNIVERSITY HOSPITAL; ATTITUDE TO HEALTH; CONFIDENTIALITY; ETHICS; INFORMATION DISSEMINATION; MIDDLE AGED; QUESTIONNAIRE; YOUNG ADULT;

ADULT; AGED; ATTITUDE TO HEALTH; CLINICAL TRIALS AS TOPIC; CONFIDENTIALITY; FEMALE; HUMANS; INFORMATION DISSEMINATION; MALE; MIDDLE AGED; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 85048301754     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsa1713258     Document Type: Article

References (63)

1. Institute of Medicine. Sharing clinical trial data: maximizing benefits, minimizing risk. Washington, DC: National Academies Press, 2015.
2. Zarin DA. Participant-level data and the new frontier in trial transparency. N Engl J Med 2013; 369: 468-9.
3. Loder E. Sharing data from clinical trials: where we are and what lies ahead. BMJ 2013; 347: f4794.
4. Mello MM, Francer JK, Wilenzick M, Teden P, Bierer BE, Barnes M. Preparing for responsible sharing of clinical trial data. N Engl J Med 2013; 369: 1651-8.
5. European Medicines Agency. Clinical data publication (http://www .ema .europa .eu/ema/?curl=pages/special-topics/general/general-content-000555 .jsp).
6. Davis AL, Miller JD.The European Medicines Agency and publication of clinical study reports: a challenge for the US FDA. JAMA 2017; 317: 905-6.
7. Food and Drug Administration. Availability of masked and de-identified nonsummary safety and efficacy data: request for comments. Fed Regist 2013; 78 107 33421-3 (https://www .federalregister .gov/articles/2013/06/04/2013-13083/availability -of-masked-and-de-identified-non-summary -safety-and-efficacy-data-request-for -comments)
8. Coady SA, Wagner E. Sharing individual level data from observational studies and clinical trials: a perspective from NHLBI. Trials 2013; 14: 201.
9. Walport M, Brest P. Sharing research data to improve public health. Lancet 2011; 377: 537-9.
10. Jumbe NL, Murray JC, Kern S. Data sharing and inductive learning - toward healthy birth, growth, and development. N Engl J Med 2016; 374: 2415-7.
11. Krumholz HM, Waldstreicher J.The Yale Open Data Access (YODA) Project - a mechanism for data sharing. N Engl J Med 2016; 375: 403-5.
12. Green AK, Reeder-Hayes KE, Corty RW, et al.The Project Data Sphere initiative: accelerating cancer research by sharing data. Oncologist 2015; 20(5): 464-e20.
13. Taichman DB, Sahni P, Pinborg A, et al. Data sharing statements for clinical trials - a requirement of the International Committee of Medical Journal Editors. N Engl J Med 2017; 376: 2277-9.
14. Warren E. Strengthening research through data sharing. N Engl J Med 2016; 375: 401-3
15. 21st Century Cures Act, Pub. L. No. 114-255 2014 (2016).
16. Majumder MA, Guerrini CJ, Bollinger JM, Cook-Deegan R, McGuire AL. Sharing data under the 21st Century Cures Act. Genet Med 2017; 19: 1289-94.
17. PhRMA, EfPIA. Principles for responsible clinical trial data sharing. 2014 (http://www .phrma .org/sites/default/files/pdf/PhRMAPrinciplesForResponsibleClinical TrialDataSharing .pdf).
18. Rockhold F, Nisen P, Freeman A. Data sharing at a crossroads. N Engl J Med 2016; 375: 1115-7.
19. Krumholz HM, Gross CP, Blount KL, et al. Sea change in open science and data sharing: leadership by industry. Circ Cardiovasc Qual Outcomes 2014; 7: 499-504.
20. Bierer BE, Li R, Barnes M, Sim I. A global, neutral platform for sharing trial data. N Engl J Med 2016; 374: 2411-3.
21. Strom BL, Buyse ME, Hughes J, Knoppers BM. Data sharing - is the juice worth the squeeze? N Engl J Med 2016; 375: 1608-9.
22. Eichler HG, Pétavy F, Pignatti F, Rasi G. Access to patient-level trial data - a boon to drug developers. N Engl J Med 2013; 369: 1577-9.
23. Shining a light on trial data. Nat Biotechnol 2012; 30: 371.
24. Krumholz HM, Ross JS. A model for dissemination and independent analysis of industry data. JAMA 2011; 306: 1593-4.
25. Whitty CJ, Mundel T, Farrar J, Heymann DL, Davies SC, Walport MJ. Providing incentives to share data early in health emergencies: the role of journal editors. Lancet 2015; 386: 1797-8.
26. Eichler HG, Abadie E, Breckenridge A, Leufkens H, Rasi G. Open clinical trial data for all? A view from regulators. PLoS Med 2012; 9(4): e1001202.
27. Gøtzsche PC. Why we need easy access to all data from all clinical trials and how to accomplish it. Trials 2011; 12: 249.
28. Lemmens T. Pharmaceutical knowledge governance: a human rights perspective. J Law Med Ethics 2013; 41: 163-84.
29. Bauchner H, Golub RM, Fontanarosa PB. Data sharing: an ethical and scientific imperative. JAMA 2016; 315: 1237-9.
30. Bertagnolli MM, Sartor O, Chabner BA, et al. Advantages of a truly open-access data-sharing model. N Engl J Med 2017; 376: 1178-81
31. PhRMA statement on clinical trials and Bad Pharma. Press release of PhRMA, February 5, 2013 (http://www .phrma .org/press-release/phrma-statement-on-clinical -trials-and-bad-pharma).
32. Rathi V, Dzara K, Gross CP, et al. Sharing of clinical trial data among trialists: a cross sectional survey. BMJ 2012; 345: e7570
33. Statement on European General Court decision on EMA. Press release of PhRMA, April 30, 2013 (http://www .phrma .org/press-release/phrma-statement-on-decision -of-the-european-general-court-on-ema -disclosure-of-company-data).
34. Berlin JA, Morris S, Rockhold F, Askie L, Ghersi D, Waldstreicher J. Bumps and bridges on the road to responsible sharing of clinical trial data. Clin Trials 2014; 11: 7-12.
35. Kaye J.The tension between data sharing and the protection of privacy in genomics research. Annu Rev Genomics Hum Genet 2012; 13: 415-31.
36. Castellani J. Are clinical trial data shared sufficiently today? Yes. BMJ 2013; 347: f1881.
37. Homer N, Szelinger S, Redman M, et al. Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS Genet 2008; 4(8): e1000167.
38. Rosenblatt M, Jain SH, Cahill M. Sharing of clinical trial data: benefits, risks, and uniform principles. Ann Intern Med 2015; 162: 306-7.
39. Alemayehu D, Anziano RJ, Levenstein M. Perspectives on clinical trial data transparency and disclosure. Contemp Clin Trials 2014; 39: 28-33.
40. Garrison NA, Sathe NA, Antommaria AHM, et al. A systematic literature review of individuals' perspectives on broad consent and data sharing in the United States. Genet Med 2016; 18: 663-71.
41. Shabani M, Bezuidenhout L, Borry P. Attitudes of research participants and the general public towards genomic data sharing: a systematic literature review. Expert Rev Mol Diagn 2014; 14: 1053-65.
42. Sample I. Big pharma mobilising patients in battle over drugs trials data.The Guardian. July 21, 2013 (https://www .theguardian .com/business/2013/jul/21/big -pharma-secret-drugs-trials).
43. Haug CJ. Whose data are they anyway? Can a patient perspective advance the datasharing debate? N Engl J Med 2017; 376: 2203-5.
44. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377-81.
45. Pentz RD, Billot L, Wendler D. Research on stored biological samples: views of African American and White American cancer patients. Am J Med Genet A 2006; 140: 733-9.
46. Kaufman DJ, Murphy-Bollinger J, Scott J, Hudson KL. Public opinion about the importance of privacy in biobank research. Am J Hum Genet 2009; 85: 643-54.
47. Helft PR, Champion VL, Eckles R, Johnson CS, Meslin EM. Cancer patients' attitudes toward future research uses of stored human biological materials. J Empir Res Hum Res Ethics 2007; 2: 15-22.
48. Beskow LM, Dean E. Informed consent for biorepositories: assessing prospective participants' understanding and opinions. Cancer Epidemiol Biomarkers Prev 2008; 17: 1440-51.
49. Gornick MC, Ryan KA, Kim SY. Impact of non-welfare interests on willingness to donate to biobanks: an experimental survey. J Empir Res Hum Res Ethics 2014; 9: 22-33.
50. Trinidad SB, Fullerton SM, Bares JM, Jarvik GP, Larson EB, Burke W. Genomic research and wide data sharing: views of prospective participants. Genet Med 2010; 12: 486-95.
51. Rogith D, Yusuf RA, Hovick SR, et al. Attitudes regarding privacy of genomic information in personalized cancer therapy. J Am Med Inform Assoc 2014; 21(e2): e320-e325.
52. Long MD, Cadigan RJ, Cook SF, et al. Perceptions of patients with inflammatory bowel diseases on biobanking. Inflamm Bowel Dis 2015; 21: 132-8.
53. Hapgood R, McCabe C, Shickle D. Public preferences for participation in a large DNA cohort study: a discrete choice experiment. HEDS discussion paper 04/05. 2004 (http://eprints .whiterose .ac .uk/10939/).
54. Grande D, Mitra N, Shah A, Wan F, Asch DA. Public preferences about secondary uses of electronic health information. JAMA Intern Med 2013; 173: 1798-806.
55. Truven Health Analytics, National Public Radio. Health poll: data privacy. November 2014 (https://truvenhealth .com/Portals/0/NPR-Truven-Health-Poll/NPRPulseData Privacy-Nov2014 .pdf).
56. Luchenski SA, Reed JE, Marston C, Papoutsi C, Majeed A, Bell D. Patient and public views on electronic health records and their uses in the United kingdom: cross-sectional survey. J Med Internet Res 2013; 15(8): e160.
57. Melas PA, Sjöholm LK, Forsner T, et al. Examining the public refusal to consent to DNA biobanking: empirical data from a Swedish population-based study. J Med Ethics 2010; 36: 93-8.
58. Storr CL, Or F, Eaton WW, Ialongo N. Genetic research participation in a young adult community sample. J Community Genet 2014; 5: 363-75.
59. Johnsson L, Helgesson G, Rafnar T, et al. Hypothetical and factual willingness to participate in biobank research. Eur J Hum Genet 2010; 18: 1261-4.
60. Stunkel L, Grady C. More than the money: a review of the literature examining healthy volunteer motivations. Contemp Clin Trials 2011; 32: 342-52.
61. Truong TH, Weeks JC, Cook EF, Joffe S. Altruism among participants in cancer clinical trials. Clin Trials 2011; 8: 616-23.
62. Oliver JM, Slashinski MJ, Wang T, Kelly PA, Hilsenbeck SG, McGuire AL. Balancing the risks and benefits of genomic data sharing: genome research participants' perspectives. Public Health Genomics 2012; 15: 106-14.
63. Sanderson SC, Brothers KB, Mercaldo ND, et al. Public attitudes toward consent and data sharing in biobank research: a large multi-site experimental survey in the US. Am J Hum Genet 2017; 100: 414-27.